Ron Renaud

Fresh from a $3.85B deal, biotech CEO sets sights on the next big thing
Fierce Biotech
Mon, 12/1/14 - 08:19 am
Ron Renaud
Merck
Idenix
RaNA
RNA
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tue, 01/28/14 - 11:17 am
Idenix
Pharma CEOs
Gilead Sciences
hepatitis C
Ron Renaud